Maine Revised Statutes Title 32 Sec. 13826 – Authorization to prescribe, dispense and administer contraceptives
Current as of: 2023 | Check for updates
|
Other versions
1. Definitions. As used in this subchapter, unless the context otherwise indicates, the following terms have the following meanings.
A. “Injectable hormonal contraceptive” means a drug composed of a hormone or a combination of hormones that is approved by the United States Food and Drug Administration to prevent pregnancy and that is administered by injection. [PL 2023, c. 115, §1 (NEW).]
B. “Self-administered hormonal contraceptive” means a drug composed of a single hormone or a combination of hormones that is approved by the United States Food and Drug Administration to prevent pregnancy and that the patient to whom the drug is prescribed may self-administer. “Self-administered hormonal contraceptive” includes an oral hormonal contraceptive, a hormonal vaginal ring and a hormonal contraceptive patch. [PL 2023, c. 115, §1 (NEW).]
[PL 2023, c. 115, §1 (NEW).]
Terms Used In Maine Revised Statutes Title 32 Sec. 13826
- Board: means the Maine Board of Pharmacy. See Maine Revised Statutes Title 32 Sec. 13702-A
- dispensing: means the preparation and delivery of a prescription drug in a suitable container appropriately labeled for subsequent administration to or use by a patient or other individual entitled to receive the prescription drug pursuant to a lawful order of a practitioner. See Maine Revised Statutes Title 32 Sec. 13702-A
- Drug: means :
A. See Maine Revised Statutes Title 32 Sec. 13702-AEvidence: Information presented in testimony or in documents that is used to persuade the fact finder (judge or jury) to decide the case for one side or the other. Injectable hormonal contraceptive: means a drug composed of a hormone or a combination of hormones that is approved by the United States Food and Drug Administration to prevent pregnancy and that is administered by injection. See Maine Revised Statutes Title 32 Sec. 13826 Pharmacist: means an individual provider of health care services licensed by this State to engage in the practice of pharmacy. See Maine Revised Statutes Title 32 Sec. 13702-A Practitioner: means an individual who is licensed, registered or otherwise authorized in the appropriate jurisdiction to prescribe and administer drugs in the course of professional practice. See Maine Revised Statutes Title 32 Sec. 13702-A Self-administered hormonal contraceptive: includes an oral hormonal contraceptive, a hormonal vaginal ring and a hormonal contraceptive patch. See Maine Revised Statutes Title 32 Sec. 13826 United States: includes territories and the District of Columbia. See Maine Revised Statutes Title 1 Sec. 72
2. Authorization. A pharmacist may prescribe, dispense or administer a self-administered hormonal contraceptive or injectable hormonal contraceptive in accordance with the requirements set forth in subsection 3.
[PL 2023, c. 115, §1 (NEW).]
3. Requirements. In order to prescribe, dispense or administer contraceptives under this section, a pharmacist shall:
A. Successfully complete a training program approved by the board related to prescribing, dispensing and administering contraceptives that reflects evidence-based medical eligibility guidelines for contraceptive use and best practices to counsel patients; [PL 2023, c. 115, §1 (NEW).]
B. Obtain a certificate of authorization issued by the board pursuant to subsection 4; [PL 2023, c. 115, §1 (NEW).]
C. Obtain a completed self-screening risk assessment from a patient prior to counseling the patient and issuing a prescription to the patient for a self-administered hormonal contraceptive or injectable hormonal contraceptive. The self-screening risk assessment and counseling provided by a pharmacist must be based on evidence-based medical eligibility guidelines for contraceptive use and best practices to counsel patients; [PL 2023, c. 115, §1 (NEW).]
D. Refer the patient to the patient’s practitioner upon dispensing a self-administered hormonal contraceptive or administering an injectable hormonal contraceptive or, if the patient does not have a practitioner responsible for the patient’s regular care, advise the patient to consult a practitioner; [PL 2023, c. 115, §1 (NEW).]
E. Provide the patient with a written record of the prescribed self-administered hormonal contraceptive or injectable hormonal contraceptive; and [PL 2023, c. 115, §1 (NEW).]
F. Dispense the self-administered hormonal contraceptive or administer the injectable hormonal contraceptive to the patient as soon as practicable after the pharmacist issues the prescription. [PL 2023, c. 115, §1 (NEW).]
[PL 2023, c. 115, §1 (NEW).]
4. Certificate of authorization. A pharmacist shall apply in the form prescribed by the board and submit a certificate fee as set forth in section 13724 for a certificate of authorization to prescribe, dispense and administer contraceptives pursuant to this section. The certificate of authorization expires and is subject to conditions in the same manner as in section 13734. The board shall issue a certificate of authorization to a pharmacist who holds a valid unrestricted license in this State and who submits evidence acceptable to the board that the pharmacist has completed the training described in subsection 3, paragraph A.
[PL 2023, c. 115, §1 (NEW).]
5. Rulemaking. The board shall adopt rules to implement the requirements of this section. Rules adopted pursuant to this subsection are routine technical rules as defined in Title 5, chapter 375, subchapter 2?A.
[PL 2023, c. 115, §1 (NEW).]
SECTION HISTORY
PL 2023, c. 115, §1 (NEW).